Literature DB >> 11462053

Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

W D Crill1, J T Roehrig.   

Abstract

The specific mechanisms by which antibodies neutralize flavivirus infectivity are not completely understood. To study these mechanisms in more detail, we analyzed the ability of a well-defined set of anti-dengue (DEN) virus E-glycoprotein-specific monoclonal antibodies (MAbs) to block virus adsorption to Vero cells. In contrast to previous studies, the binding sites of these MAbs were localized to one of three structural domains (I, II, and III) in the E glycoprotein. The results indicate that most MAbs that neutralize virus infectivity do so, at least in part, by the blocking of virus adsorption. However, MAbs specific for domain III were the strongest blockers of virus adsorption. These results extend our understanding of the structure-function relationships in the E glycoprotein of DEN virus and provide the first direct evidence that domain III encodes the primary flavivirus receptor-binding motif.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462053      PMCID: PMC115016          DOI: 10.1128/JVI.75.16.7769-7773.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

Authors:  S Bhardwaj; M Holbrook; R E Shope; A D Barrett; S J Watowich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.

Authors:  E A Henchal; J M McCown; D S Burke; M C Seguin; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1985-01       Impact factor: 2.345

4.  Analysis of the steps involved in Dengue virus entry into host cells.

Authors:  S L Hung; P L Lee; H W Chen; L K Chen; C L Kao; C C King
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

5.  Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein.

Authors:  F X Heinz; C Mandl; R Berger; W Tuma; C Kunz
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

6.  Alteration of virus entry mode: a neutralisation mechanism for Dengue-2 virus.

Authors:  S Y Se-Thoe; A E Ling; M M Ng
Journal:  J Med Virol       Date:  2000-11       Impact factor: 2.327

7.  Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.

Authors:  C W Mandl; S L Allison; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein.

Authors:  R G van der Most; J Corver; J H Strauss
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

9.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

10.  A new mechanism for the neutralization of enveloped viruses by antiviral antibody.

Authors:  S W Gollins; J S Porterfield
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

View more
  229 in total

1.  Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Authors:  David W C Beasley; Alan D T Barrett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

3.  Visualization of membrane protein domains by cryo-electron microscopy of dengue virus.

Authors:  Wei Zhang; Paul R Chipman; Jeroen Corver; Peter R Johnson; Ying Zhang; Suchetana Mukhopadhyay; Timothy S Baker; James H Strauss; Michael G Rossmann; Richard J Kuhn
Journal:  Nat Struct Biol       Date:  2003-10-05

4.  Structures of immature flavivirus particles.

Authors:  Ying Zhang; Jeroen Corver; Paul R Chipman; Wei Zhang; Sergei V Pletnev; Dagmar Sedlak; Timothy S Baker; James H Strauss; Richard J Kuhn; Michael G Rossmann
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

5.  Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.

Authors:  Michael R Holbrook; Robert E Shope; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

6.  Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein.

Authors:  John T Roehrig; Katharine E Volpe; Jennifer Squires; Ann R Hunt; Brent S Davis; Gwong-Jen J Chang
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  Positive selection sites in the surface genes of dengue virus: phylogenetic analysis of the interserotypic branches of the four serotypes.

Authors:  Patsarin Rodpothong; Prasert Auewarakul
Journal:  Virus Genes       Date:  2012-01-06       Impact factor: 2.332

9.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity.

Authors:  Jill A Roberson; Wayne D Crill; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.